PMI on track to submit PMTA to market its new Iqos vapour device in the US

Philip Morris International (PMI) has announced that it is continuing preparations to submit a premarket tobacco product application (PMTA) to the US Food and Drug Administration (FDA) in the second half of next year for a new Iqos e-vapour device.

The manufacturer said during its third-quarter earnings presentation that the product was making “good progress” in the markets where it has been launched so far.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us